Skip to main content

Advertisement

SpringerLink
Log in

Do cancer patients undergoing surgery for a non-neoplastic related fragility hip fracture have worse outcomes? A retrospective study

  • Orthopaedic Surgery
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Introduction

An increasing number of patients sustaining a fragility hip fracture (FHF) have either an active diagnosis or a history of cancer. However, little is known about the outcomes of non-malignant related FHF in this group of patients. We aimed to evaluate the mortality and complications rates during hospitalization, as well as at 1-year follow-up within this population.

Methods

A retrospective cohort study of patients 65 years of age and above, who underwent surgery for the treatment of proximal femoral fractures between January 2012 and June 2016 was conducted. Patients diagnosed with malignancies, both solid (Carcinomas) and a hematological neoplasias (Lymphomas, Multiple Myeloma) were included, along with consecutive controls without a diagnosis of cancer in the 5 years prior to the study period. Demographic, clinical and radiographic parameters were recorded and analyzed.

Results

Seven hundred and fifty-two patients with FHF were included, of whom 51 had a malignancy diagnosis within the 5-year period preceding the fracture (18% metastatic disease). The mean time from malignancy diagnosis to FHF was 4.3 ± 4.8 years. Time to surgery did not differ between groups, and the vast majority of patients from both groups (over 87%) were operated within the desirable 48 h from admission. Patients with malignancy had a higher probability of being admitted to an internal medicine department both pre and post-surgically (p < 0.001), and were more susceptible to pre-operative anemia (p = 0.034). In-hospital mortality did not differ between groups, yet 1-year mortality was higher for the malignancy group (41.2% vs 19.5%, p < 0.001). At 1-year post-operatively, orthopedic complications were similar between groups.

Conclusion

Patients with a history of malignancy in the 5-years prior to a non-neoplastic FHF, showed similar mortality and complications rates during admission but increased 1 year mortality rate when compared to patients without cancer undergoing surgical treatment of a non-neoplastic proximal femoral fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30. https://doi.org/10.3322/caac.21332

    Article  Google Scholar 

  2. Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL et al (2016) Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122:1312–1337. https://doi.org/10.1002/cncr.29936

    Article  Google Scholar 

  3. Rosas S, Sabeh K, Kurowicki J, Buller L, Law TY, Roche M et al (2017) National use of total hip arthroplasty among patients with a history of breast, lung, prostate, colon or bladder cancer-an analysis of the Medicare population. Ann Transl Med 5:S34. https://doi.org/10.21037/atm.2017.11.18

    Article  Google Scholar 

  4. Karam JA, Huang RC, Abraham JA, Parvizi J (2015) Total joint arthroplasty in cancer patients. J Arthroplasty 30:758–761. https://doi.org/10.1016/j.arth.2014.12.017

    Article  Google Scholar 

  5. Ryan DJ, Yoshihara H, Yoneoka D, Egol KA, Zuckerman JD (2015) Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma 29:343–348. https://doi.org/10.1097/BOT.0000000000000313

    Article  Google Scholar 

  6. Shiga T, Wajima Z, Ohe Y (2008) Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 55:146–154. https://doi.org/10.1007/BF03016088

    Article  Google Scholar 

  7. Lawrence JE, Fountain DM, Cundall-Curry DJ, Carrothers AD (2017) Do patients taking warfarin experience delays to theatre, longer hospital stay, and poorer survival after hip fracture? Clin Orthop Relat Res 475:273–279. https://doi.org/10.1007/s11999-016-5056-0

    Article  Google Scholar 

  8. White RH, Zhou H, Romano PS (2003) Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90:446–455. https://doi.org/10.1160/TH03-03-0152

    Article  CAS  Google Scholar 

  9. Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN et al (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162:1245–1248

    Article  Google Scholar 

  10. Memtsoudis SG, Pumberger M, Ma Y, Chiu Y-L, Fritsch G, Gerner P et al (2012) Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res 30:1811–1821. https://doi.org/10.1002/jor.22139

    Article  Google Scholar 

  11. Mantilla CB, Wass CT, Goodrich KA, Johanns CJ, Kool ML, Zhu X et al (2011) Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia. Transfusion 51:82–91. https://doi.org/10.1111/j.1537-2995.2010.02797.x

    Article  Google Scholar 

  12. Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ (2012) Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res 470:130–137. https://doi.org/10.1007/s11999-011-2043-3

    Article  Google Scholar 

  13. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP et al (2012) Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 94:794–800. https://doi.org/10.2106/JBJS.K.00072

    Article  Google Scholar 

  14. Leung F, Lau TW, Kwan K, Chow SP, Kung AW (2010) Does timing of surgery matter in fragility hip fractures? Osteoporos Int 21:S529–S534. https://doi.org/10.1007/s00198-010-1391-2

    Article  CAS  Google Scholar 

  15. Eardley WG, Macleod KE, Freeman H, Tate A (2014) “Tiers of delay”: warfarin, hip fractures, and target-driven care. Geriatr Orthop Surg Rehabil 5:103–108. https://doi.org/10.1177/2151458514532469

    Article  CAS  Google Scholar 

  16. Ftouh S, Morga A, Swift C, Group GD (2011) Management of hip fracture in adults: summary of NICE guidance. BMJ 342:d3304. https://doi.org/10.1136/bmj.d3304

    Article  Google Scholar 

  17. Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ (2009) Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury 40:692–697. https://doi.org/10.1016/j.injury.2009.01.010

    Article  Google Scholar 

  18. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  Google Scholar 

  19. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682. https://doi.org/10.1093/aje/kwq433

    Article  Google Scholar 

  20. Frenkel Rutenberg T, Aizer A, Levi A, Naftali N, Zeituni S, Velkes S et al (2020) Antibiotic prophylaxis as a quality of care indicator: does it help in the fight against surgical site infections following fragility hip fractures? Arch Orthop Trauma Surg. https://doi.org/10.1007/s00402-020-03682-2

    Article  Google Scholar 

  21. Frenkel Rutenberg T, Vitenberg M, Haviv B, Velkes S (2018) Timing of physiotherapy following fragility hip fracture: delays cost lives. Arch Orthop Trauma Surg 138:1519–1524. https://doi.org/10.1007/s00402-018-3010-1

    Article  Google Scholar 

  22. Ottanelli S (2015) Prevention and treatment of bone fragility in cancer patient. Clin Cases Miner Bone Metab Off J Ital Soc Osteoporos Miner Metab Skelet Dis 12:116–129. https://doi.org/10.11138/ccmbm/2015.12.2.116

    Article  Google Scholar 

  23. Rachner TD, Coleman R, Hadji P, Hofbauer LC (2018) Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol 6:901–910. https://doi.org/10.1016/S2213-8587(18)30047-0

    Article  CAS  Google Scholar 

  24. Cianferotti L, Bertoldo F, Carini M, Kanis JA, Lapini A, Longo N et al (2017) The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation. Oncotarget 8:75646–75663. https://doi.org/10.18632/oncotarget.17980

    Article  Google Scholar 

  25. Peichl P, Holzer LA, Maier R, Holzer G (2011) Parathyroid hormone 1–84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 93:1583–1587. https://doi.org/10.2106/JBJS.J.01379

    Article  Google Scholar 

  26. Suhm N, Egger A, Zech C, Eckhardt H, Morgenstern M, Gratza S (2020) Low acceptance of osteoanabolic therapy with parathyroid hormone in patients with fragility fracture of the pelvis in routine clinical practice: a retrospective observational cohort study. Arch Orthop Trauma Surg 140:321–329. https://doi.org/10.1007/s00402-019-03241-4

    Article  Google Scholar 

  27. Leer-Salvesen S, Engesæter LB, Dybvik E, Furnes O, Kristensen TB, Gjertsen J-E (2019) Does time from fracture to surgery affect mortality and intraoperative medical complications for hip fracture patients? An observational study of 73 557 patients reported to the Norwegian hip fracture register. Bone Joint J 101:1129–1137

    Article  Google Scholar 

  28. Dorotka R, Schoechtner H, Buchinger W (2003) The influence of immediate surgical treatment of proximal femoral fractures on mortality and quality of life. Operation within six hours of the fracture versus later than six hours. J Bone Joint Surg Br 85:1107–1113

    Article  CAS  Google Scholar 

  29. Mitchell SM, Chung AS, Walker JB, Hustedt JW, Russell GV, Jones CB (2018) Delay in hip fracture surgery prolongs postoperative hospital length of stay but does not adversely affect outcomes at 30 days. J Orthop Trauma 32:629–633. https://doi.org/10.1097/BOT.0000000000001306

    Article  Google Scholar 

  30. Frenkel Rutenberg T, Velkes S, Vitenberg M, Leader A, Halavy Y, Raanani P et al (2018) Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants. Thromb Res 166:106–112. https://doi.org/10.1016/j.thromres.2018.04.022

    Article  CAS  Google Scholar 

  31. Yombi JC, Putineanu DC, Cornu O, Lavand’homme P, Cornette P, Castanares-Zapatero D (2019) Low haemoglobin at admission is associated with mortality after hip fractures in elderly patients. Bone Joint J 101:1122–1128. https://doi.org/10.1302/0301-620X.101B9.BJJ-2019-0526.R1

    Article  Google Scholar 

  32. Sim YE, Sim SED, Seng C, Howe TS, Koh SB, Abdullah HR (2018) preoperative anemia, functional outcomes, and quality of life after hip fracture surgery. J Am Geriatr Soc 66:1524–1531. https://doi.org/10.1111/jgs.15428

    Article  Google Scholar 

  33. Smith GH, Tsang J, Molyneux SG, White TO (2011) The hidden blood loss after hip fracture. Injury 42:133–135. https://doi.org/10.1016/j.injury.2010.02.015

    Article  CAS  Google Scholar 

  34. Khan SK, Rushton SP, Courtney M, Gray AC, Deehan DJ (2013) Elderly men with renal dysfunction are most at risk for poor outcome after neck of femur fractures. Age Ageing 42:76–81. https://doi.org/10.1093/ageing/afs152

    Article  Google Scholar 

  35. Porter CJ, Moppett IK, Juurlink I, Nightingale J, Moran CG, Devonald MAJ (2017) Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injury. BMC Nephrol 18:20. https://doi.org/10.1186/s12882-017-0437-5

    Article  Google Scholar 

  36. Donnellan E, Khorana AA (2017) Cancer and venous thromboembolic disease: a review. Oncologist 22:199–207. https://doi.org/10.1634/theoncologist.2016-0214

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Orthopedic Department, Rabin Medical Center, Beilinson Hospital, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Tal Frenkel Rutenberg, Maria Vitenberg, Efrat Daglan & Shai Shemesh

  2. Orthopedic Department, Musculoskeletal Oncology Division, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA

    Juan Pretell-Mazzini

Authors
  1. Tal Frenkel Rutenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Vitenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Efrat Daglan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juan Pretell-Mazzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shai Shemesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Pretell-Mazzini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rutenberg, T.F., Vitenberg, M., Daglan, E. et al. Do cancer patients undergoing surgery for a non-neoplastic related fragility hip fracture have worse outcomes? A retrospective study. Arch Orthop Trauma Surg 143, 9–17 (2023). https://doi.org/10.1007/s00402-021-03976-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-021-03976-z

Keywords

Search

Navigation